Possible 指定 against 大日本住友製薬 株式会社
For developers: integration details
You do not need this for normal browsing. Use it when integrating this enforcement record into an internal tool or AI workflow.
/api/v1/enforcements?company=%E5%A4%A7%E6%97%A5%E6%9C%AC%E4%BD%8F%E5%8F%8B%E8%A3%BD%E8%96%AC%E6%A0%AA%E5%BC%8F%E4%BC%9A%E7%A4%BE&limit=10Action summary
- Company
- 大日本住友製薬 株式会社Japanese originalOriginal: 大日本住友製薬株式会社
- Entity match
- Possible entity match60/100Machine extractedCompany name extracted from the Japanese public disclosure
- Governing law
- Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices薬機法
- Action type
- 指定指定
- Action date
- 28 February 2017
- Issuing authority
- Ministry of Health, Labour and Welfare厚生労働省
Violation
Show original Japanese text
パーキンソン病に対するiPS細胞由来のドパミン神経前駆細胞を用いた治療。
Compliance context
Context neededThis is a public Japanese regulatory disclosure. The exact legal effect depends on the cited source and regulator.
Health product law covering pharmaceuticals, medical devices, cosmetics, quasi-drugs, labeling, and advertising.
Review the original Japanese source and determine relevance to your counterparty-risk workflow.
This context is an operational aid for review workflows, not a credit opinion or legal conclusion.
Evidence pack
- Extracted at
- 2026-05-02T12:01:55.672+00:00
- Evidence checked
- 2026-05-02T12:01:55.672+00:00
- Archive captured
- 2026-05-02T12:01:56.056+00:00
Show audit JSON
{
"record": {
"id": "5dd9a1cd-b619-4b74-9645-897bd4ec845e",
"url": "https://regbase.jp/en/enforcement/yakkiho-da-ri-ben-zhu-you-zhi-yao-20170228",
"company_name_original": "大日本住友製薬株式会社",
"company_name_registry": "大日本住友製薬 株式会社",
"corporate_number": null,
"law": {
"ja": "薬機法",
"en": "Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices"
},
"action_type": {
"ja": "指定",
"en": "指定"
},
"authority": {
"ja": "厚生労働省",
"en": "Ministry of Health, Labour and Welfare"
}
},
"entity_match": {
"status": "possible",
"confidence": 60,
"method": "extracted_japanese_name",
"method_label": "Company name extracted from the Japanese public disclosure",
"notes": null
},
"review": {
"status": "unreviewed",
"label": "Machine extracted"
},
"compliance_context": {
"severity": "Context needed",
"actionMeaning": "This is a public Japanese regulatory disclosure. The exact legal effect depends on the cited source and regulator.",
"practicalNote": "Review the original Japanese source and determine relevance to your counterparty-risk workflow.",
"lawContext": "Health product law covering pharmaceuticals, medical devices, cosmetics, quasi-drugs, labeling, and advertising."
},
"evidence": {
"recordUrl": "https://regbase.jp/en/enforcement/yakkiho-da-ri-ben-zhu-you-zhi-yao-20170228",
"officialSourceUrl": "https://www.mhlw.go.jp/stf/houdou/0000153128.html",
"archiveUrl": "https://kiroku.today/view/60d0baf7afoak2ny",
"archiveCapturedAt": "2026-05-02T12:01:56.056+00:00",
"extractedAt": "2026-05-02T12:01:55.672+00:00",
"translatedAt": null,
"evidenceCheckedAt": "2026-05-02T12:01:55.672+00:00",
"generatedAt": "2026-06-19T09:18:33.191Z"
},
"limitations": [
"RegBase aggregates public Japanese government disclosures and does not provide a credit opinion.",
"English summaries are provided for reference. The original Japanese source is authoritative.",
"Possible or unresolved entity matches should be manually verified before use in a decision."
]
}The original Japanese disclosure is the authoritative record. Use possible or unresolved matches only as leads for manual review.
Language
日本語版を見る (Japanese)Company info
- English name
- 大日本住友製薬 株式会社 Japanese original
- Japanese name
- 大日本住友製薬 株式会社
About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.